U.S. Government Pockets $400 Million from Moderna mRNA COVID Shots
A recently disclosed contract reveals that the U.S. government received millions of dollars in licensing fees from Moderna, Inc. The company paid the National Institutes of Health (NIH) $400 million to use NIH’s spike protein technology in Moderna’s Spikevax messenger RNA (mRNA) COVID-19 biologic.1 2 The large payment was part of a royalty-bearing license agreement […]
Jacking Up the Price of Lemons: The COVID Vaccine Scam
In July 2020, the U.S. government ordered 100 million doses of Pfizer/BioNTech’s experimental BNT162b2 (now known as Comirnaty) messenger RNA (mRNA) COVID-19 biologic for $1.95 billion, or $19.50 per dose. A few months later in December, it followed up with a second order for another 100 million doses of the shot for the same price.1 […]
Developers of mRNA COVID Shots Spar Over Intellectual Property Rights
Pfizer and BioNTech will have to answer in court to legal claims by Moderna that they copied its innovative messenger RNA (mRNA) technology in the making of their COVID-19 biologic, Comirnaty. The patent infringement lawsuit filed in U.S. District Court for the District of Massachusetts and the Regional Court of Dusseldorf in Germany alleges that […]
Moderna CEO Was Paid $18.2 Million in 2021
As COVID-19 vaccine sales continue to soar, Moderna Chief Executive Stephane Bancel’s total personal financial compensation increased by 41 percent in 2021, reaching $18.2 million. The company’s total revenue rose 2,200 percent in 2021, jumping from $803 million to $18.5 billion.1 2 Moderna partnered with the National Institute of Allergy and Infectious Diseases (NIAID), headed […]
Renewable Travel Pass May Signal Annual Booster Shots for European Union
As part of an effort to reopen their borders and encourage travelers from outside of Europe, the 27 member states of the European Union (E.U.) began issuing an “E.U. Digital COVID Certificate” (EUDCC) on July 1, 2021 to people who have receive COVID vaccinations to allow freedom of movement within the region. The travel scheme, […]
Moderna, Novavax Developing Combined Single-Dose COVID-19 and Influenza Vaccine
American pharmaceutical and biotechnology company Moderna, Inc., which partnered with the U.S. National Institutes of Allergy and Infectious Diseases (NIAID) to develop an mRNA COVID-19 vaccine being distributed in the United States under an Emergency Use Authorization (EUA) announced that it is developing a combined single-dose booster vaccine for COVID-19 and seasonal influenza.1 In a […]
